Trademark: 86945392
Word
LIPAD
Status Date
Tuesday, May 28, 2019
Registration Number
5760160
Registration Date
Tuesday, May 28, 2019
Filing Date
Friday, March 18, 2016
Published for Opposition
Tuesday, March 12, 2019
5 Allergy medications; antibacterial pharmaceuticals; antibiotic preparations; antibiotics; antifungal preparations; anti-cancer preparations; anti-diabetic preparations; anti-inflammatories; aspirin; lipid-based preparations for medical or clinical use; cardiovascular treatment preparations; cells for medical or clinical use; chemotherapeutics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated skin care preparations; ophthalmic preparations; pain relief medication; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; radioactive pharmaceutical preparations for therapeutic use
42 Biochemical research and development; biomedical research services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; chemical, biochemical, biological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems
Jun 28, 2016
Non-Final Action Written
Mar 22, 2016
New Application Entered
Mar 23, 2016
New Application Office Supplied Data Entered
Jun 28, 2016
Assigned To Examiner
Jun 28, 2016
Non-Final Action E-Mailed
Jun 28, 2016
Notification Of Non-Final Action E-Mailed
Sep 8, 2016
Teas Voluntary Amendment Received
Sep 8, 2016
Preliminary/Voluntary Amendment - Entered
Sep 12, 2016
Report Unresponsive Amendment - Completed
Sep 12, 2016
Notice Of Unresponsive Amendment - E-Mailed
Sep 12, 2016
Notification Of Notice Of Unresponsive Amendment - E-Mailed
Dec 27, 2016
Teas Response To Office Action Received
Jan 20, 2017
Assigned To Lie
Jan 25, 2017
Correspondence Received In Law Office
Jan 25, 2017
Teas/Email Correspondence Entered
Jan 27, 2017
Approved For Pub - Principal Register
Feb 13, 2017
Law Office Publication Review Completed
Mar 1, 2017
Notification Of Notice Of Publication E-Mailed
Mar 21, 2017
Published For Opposition
Mar 21, 2017
Official Gazette Publication Confirmation E-Mailed
May 16, 2017
Noa E-Mailed - Sou Required From Applicant
Nov 16, 2017
Sou Teas Extension Received
Nov 16, 2017
Sou Extension 1 Filed
Nov 16, 2017
Sou Extension 1 Granted
Nov 18, 2017
Notice Of Approval Of Extension Request E-Mailed
May 16, 2018
Sou Teas Extension Received
May 16, 2018
Sou Extension 2 Filed
May 16, 2018
Sou Extension 2 Granted
May 18, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2018
Sou Teas Extension Received
Nov 2, 2018
Sou Extension 3 Filed
Nov 2, 2018
Sou Extension 3 Granted
Nov 2, 2018
Teas Petition To Director Received
Nov 6, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2019
Notice Of Allowance Cancelled
Jan 14, 2019
Assigned To Petition Staff
Jan 14, 2019
Petition Inquiry Letter Issued
Jan 14, 2019
Teas Response To Petition Inquiry Letter
Jan 22, 2019
Petition To Director - Change Basis - Granted
Jan 22, 2019
Attorney Review/Decision On Amendment Required
Jan 28, 2019
Case Returned To Examination
Jan 29, 2019
Previous Allowance Count Withdrawn
Jan 29, 2019
Approved For Pub - Principal Register
Feb 6, 2019
Law Office Publication Review Completed
Feb 20, 2019
Notification Of Notice Of Publication E-Mailed
Mar 12, 2019
Published For Opposition
Mar 12, 2019
Official Gazette Publication Confirmation E-Mailed
May 28, 2019
Registered-Principal Register
Dec 23, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 28, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 16, 2024
Teas Section 8 & 15 Received
Dec 23, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 23, 2022
Teas Change Of Domestic Representatives Address
Dec 23, 2022
Teas Change Of Correspondence Received
Trademark Alertz updated from USPTO on 2030-01-24
